Search - tctmd.com

Displaying 141 - 160 of 1092

Sort: Relevancy | Date

Presentation NY Valves 2024

Case Resolution

Presenter: Rodrigo D. Estevez-Loureiro

June 07, 2024

Presentation NY Valves 2024

TTVI in in the Failing Right Heart

Presenter: JoAnn Lindenfeld

June 07, 2024

Presentation NY Valves 2024

Case Presentation

Presenter: Rodrigo D. Estevez-Loureiro

June 07, 2024

Presentation NY Valves 2024

What is the Optimal Post-LAAO Antithrombotic Regimen?

Presenter: Sameer Gafoor

June 07, 2024

Presentation NY Valves 2024

Device-Related Thrombus Post-LAAO: Diagnosis, Prevention, & Management

Presenter: Amit N. Vora

June 07, 2024

Presentation NY Valves 2024

Acute and Delayed Cardiac Tamponade with LAAO: Causes & Management

Presenter: Jean-Michel Paradis

June 07, 2024

Presentation NY Valves 2024

Treatment of LAAO Peri-Device Leak: Transcatheter Options

Presenter: Rodney Horton

June 07, 2024

Presentation NY Valves 2024

When is Post-LAAO Peri-Device Leak Significant?

Presenter: Christine J. Chung

June 07, 2024

Presentation NY Valves 2024

Unsuccessful or Complicated Leaflet Modification in TAVR

Presenter: Isida Byku

June 06, 2024

Presentation NY Valves 2024

Leaflet Modification for TAV-in-TAV

Presenter: Adam B. Greenbaum

June 06, 2024

Presentation NY Valves 2024

TELLTALE for TAV-in-SAV or TAV-in-Native

Presenter: Toby Rogers

June 06, 2024

Presentation NY Valves 2024

BASILICA or ShortCut for TAV-in-SAVR or TAV-in-TAV

Presenter: Philippe Genereux

June 06, 2024

Presentation NY Valves 2024

RAVR or TAVR as an Interventional Cardiologist – My Clinical Decision Making

Presenter: Ramesh Daggubati

June 06, 2024

Presentation NY Valves 2024

Is Leaflet Modification Sufficient to Prevent Coronary Obstruction - When to Consider Snorkel Stenting

Presenter: Antonio Mangieri

June 06, 2024

Presentation NY Valves 2024

The 2024 'Toolbox' for Leaflet Modification in TAVR

Presenter: Jaffar M. Khan

June 06, 2024

Presentation NY Valves 2024

Can TAV-in-TAV Simulations be Useful in Procedural Planning?

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

How to Interpret the Pathology Data From TAVR Explants

Presenter: Stephanie Sellers

June 06, 2024

Presentation NY Valves 2024

The Future is Now! TAVR is a Favorable Alternative in AS Patients Under 65 Years Old

Presenter: Bernard Prendergast

June 06, 2024

Presentation NY Valves 2024

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

Presenter: Keith B. Allen

June 06, 2024

Presentation NY Valves 2024

TAVR in Young Patients - Current Treatment Patterns in the US

Presenter: Mayra Guerrero

June 06, 2024

Advertisement

Case Resolution

TTVI in in the Failing Right Heart

Case Presentation

What is the Optimal Post-LAAO Antithrombotic Regimen?

Device-Related Thrombus Post-LAAO: Diagnosis, Prevention, & Management

Acute and Delayed Cardiac Tamponade with LAAO: Causes & Management

Treatment of LAAO Peri-Device Leak: Transcatheter Options

When is Post-LAAO Peri-Device Leak Significant?

Unsuccessful or Complicated Leaflet Modification in TAVR

Leaflet Modification for TAV-in-TAV

TELLTALE for TAV-in-SAV or TAV-in-Native

BASILICA or ShortCut for TAV-in-SAVR or TAV-in-TAV

RAVR or TAVR as an Interventional Cardiologist – My Clinical Decision Making

Is Leaflet Modification Sufficient to Prevent Coronary Obstruction - When to Consider Snorkel Stenting

The 2024 'Toolbox' for Leaflet Modification in TAVR

Can TAV-in-TAV Simulations be Useful in Procedural Planning?

How to Interpret the Pathology Data From TAVR Explants

The Future is Now! TAVR is a Favorable Alternative in AS Patients Under 65 Years Old

SAVR is Clearly the Gold Standard in AS Patients Under 65 Years Old

TAVR in Young Patients - Current Treatment Patterns in the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content